Incentive Spirometer and Inspiratory Muscle Trainer

Parkinson Disease Clinical Trial

Official title:

A Comparative Study of Incentive Spirometer Versus Inspiratory Muscle Trainer on Pulmonary Function in Patients With Parkinsonism

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05201742
• Other study ID #: GSITESC/24/16
• Status: Completed
• Phase: N/A
• Start date: February 6, 2017
• Est. completion date: May 10, 2018

Study information

• Verified date: January 2022
• Source: King Saud University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patients suffering from parkinsonism have respiratory function abnormalities. This study compared the effects of incentive spirometer and inspiratory muscle trainer on pulmonary functions in patients with parkinsonism.

Description:

The participants were recruited according to the inclusion and exclusion criteria. Participants were divided into two groups - incentive spirometer and inspiratory muscle trainer. These trainings were performed for 6 weeks duration. Several outcome measures related to pulmonary function tests were measured before and after the intervention.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: May 10, 2018
• Est. primary completion date: January 18, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years to 75 Years

Eligibility

Inclusion Criteria:

• Patients diagnosed as having Parkinsonism Disease by the Neuro physician.

• Duration of Parkinson's Disease = 5 years.

• Patients with the age of 65 to 80 years.

• Hoen and Yahr classification within 1 to 3.

• Both males and females were included.

• Patients who were able to comprehend the commands.

• Patients who were willing to participate.

Exclusion Criteria:

• Patients having any cardiovascular and pulmonary disorders.

• History of smoking currently or in the past.

• Psychological Impairment.

• Insufficient verbal/intellectual understanding.

• Patients with unstable vital parameters.

• Those unable to perform pulmonary function tests (PFT) because of anatomical abnormalities or clinical signs of dementia.

Related Conditions & MeSH terms

• Parkinson Disease
• Respiratory Aspiration

Intervention

Other:
• Inspiratory muscle training
Threshold inspiratory muscle training was performed for 6 weeks with device.
• Incentive Spirometry
Incentive spirometry was performed for 6 weeks with device.

Locations

Country	Name	City	State
Saudi Arabia	King Saud University	Riyadh

Sponsors (1)

Lead Sponsor	Collaborator
King Saud University

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Maximum inspiratory pressure (MIP)	Maximum inspiratory pressure was measured.	6 weeks
Primary	6-minute walk distance (6 MWD)	Distance walked by the patients in 6 minutes was measured.	6 weeks
Primary	Forced vital capacity (FVC)	Forced vital capacity was measured.	6 weeks
Primary	Forced expiratory volume in 1 second (FEV1)	Forced expiratory volume in 1 second was measured	6 weeks
Primary	Peak Expiratory Flow Rate (PEFR)	Peak Expiratory Flow Rate was measured	6 weeks